The Electrochemical Society

Adjusting to a Changed World

Mark Orazem on a Sabbatical that Doesn’t go According to Plan
11-Aug-2020 12:45 PM EDT, by The Electrochemical Society

Sabbatical goal achieved: Book proposal to ECS Monograph Series

Newswise — “The main purpose of my sabbatical has been working on a book with my collaborator, Bernard Tribollet. On previous sabbaticals over the past 25 years, I’ve travelled to Paris to collaborate with him. Bernard and I published a book on electrochemical impedance spectroscopy in 2008, and the second edition was published in 2017. What we’re working on now—remotely—is basically a problem-solving book. I am happy to say that one of my goals for the year, to start the process on that book, was accomplished. We wrote the proposal and submitted it to Wiley to be considered for publication as part of the ECS monograph series.”

Sabbatical plans for travel interrupted

“I went to Santiago, Chile, and to the University of Seville in Spain. Then health issues prevented me taking a trip to China in December—glad I didn’t go! I was also supposed to lecture at the university in Prague in mid-April. But by early March, it was clear that the world was facing a real problem. So I postponed that trip. At that point, UF was saying, ‘We don’t want you to travel. We’re not forbidding it, but we discourage foreign travel.’  So I advised ECS that it would be difficult for me to attend the Montreal meeting. The Society canceled the meeting, which was the right thing to do. 

I was scheduled to give my short course on chemical industrial safety at the Montreal meeting. I’ve been teaching this for the Society since 2000. It’s popular and I’m supposed to teach the course at PRiME. I’m scheduled to chair a session there and submitted a couple of abstracts. I want to attend PRiME, but I haven’t been as aggressive about preparing for it as I normally would be. It’s not clear if it will be safe to travel by October. The experts tell us there are certain things that need to happen; it doesn’t seem that they are.” 

Prolonging the pandemic pivot

“I return to teaching in the fall. My research is in electrochemistry and electrochemical engineering, but I teach industrial safety, on how to recognize and mitigate risky situations in a company environment. I’m really grateful that I didn’t suddenly have to pivot to online teaching. I’ve got time to think about it and talk with people whose teaching I respect. All UF courses were online as of March. The university anticipates that fall term will also be online. I am sure I can learn from my colleagues who transitioned their courses within weeks. They came up with good ideas. 

Even though I am on sabbatical, I still manage my research group. The way I work with my students is very interactive. On campus, my office is right across the hall from my students’ labs. I frequently walk through the lab, talk to people, and see what they’re doing. We have weekly formal individual and group meetings, now via Zoom. 

My students have continued their research which is probably about 60 percent modeling and 40 percent experimental. They do more modeling work, with remote access to all the software. However, there are experiments that we can’t do right now. We are waiting until UF decides it’s safe for us to return to the lab. 

I think that I should teach an online version of my ECS short course. When the monograph is done, maybe. I’m juggling a lot of balls!”

It’s all about interaction

“Though I do present papers, attend sessions, and deliver my short course, the primary reason I go to ECS meetings is to engage with colleagues in my field. You can do a lot one-on-one virtually, but something unique is gained in person. The connections I’ve made with people all over the world mean a lot to me. For example, early on I received a surprise shipment of masks from a colleague in China. His personal note shared what he had learned from his community‘s experience. It was very touching and helpful, especially when my wife and daughter were ill.

My fall course will be part lecture, part videos, and a few guest speakers ‘Zooming in’ from OSHA or other places. I don’t like using mostly PowerPoint in my lectures because it creates a barrier—and more so on Zoom. I’m going to broadcast what I write during a lecture on a pad of paper, the same way I would write on the blackboard.

Probably my biggest concern is how to recreate class engagement remotely. In my group meetings, I’ve started asking my students to share a two-slide summary of what they’ve been doing. In addition to that, once per semester, each student will present a safety moment or deliver a conference-style presentation. It’s good practice for them. Everyone gets to know what everyone else in the group is doing, creating a group rapport. Everyone seems to love it.”

Filters close

Showing results

110 of 3821
Newswise: UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
Released: 28-Oct-2020 5:20 PM EDT
UC Davis Health announces Post-COVID-19 Clinic for long-haul patients
UC Davis Health

UC Davis Health is one of only a handful of health systems in the U.S. to launch a Post-COVID-19 Clinic to care for long-haul COVID patients whose symptoms go on and on, sometimes for months, with no clear explanation or avenue for treatment.

Newswise: Most People Mount a Strong Antibody Response to 
SARS-CoV-2 That Does Not Decline Rapidly
Released: 28-Oct-2020 5:20 PM EDT
Most People Mount a Strong Antibody Response to SARS-CoV-2 That Does Not Decline Rapidly
Mount Sinai Health System

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

Newswise: 45a1c2a0-c0a4-11ea-b53e-cb3f2ed770b1.jpg
Released: 28-Oct-2020 4:00 PM EDT
Investigator on the AtraZeneca vaccine trial will take questions at Live Event on Oct. 29, 3PM
Keck Medicine of USC

Dr. Edward Jones-Lopez, joins a Newswise Live Expert Panel on Thursday Oct. 29, from 3-4 PM EDT to discuss the AstraZenea COVID-19 vaccine trial.

Released: 28-Oct-2020 4:00 PM EDT
"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT

"Third spike" in COVID-19 cases, plus the vaccine trials: Live Expert Panel for October 29, 3PM EDT

Newswise: Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida
Released: 28-Oct-2020 2:15 PM EDT
Oak Ridge National Laboratory industry collaboration enables job growth, N95 mask production in Florida
Oak Ridge National Laboratory

A collaboration between the Department of Energy’s Oak Ridge National Laboratory and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.

Released: 28-Oct-2020 1:55 PM EDT
What EEGs tell us about COVID-19 and the brain
Baylor College of Medicine

Throughout the pandemic, healthcare workers have seen more than just the lungs affected by COVID-19. Doctors have reported neurological complications including stroke, headache and seizures, but the information is limited to a number of individual reports that are not reflective of a larger population.

Released: 28-Oct-2020 1:50 PM EDT
A new playbook: COVID-19, athletes' hearts and return to play
Massachusetts General Hospital

Reports have indicated that COVID-19 may cause heart damage in hospitalized patients with severe cases of the disease, but it's unclear whether cardiac injury also occurs in infected patients who are asymptomatic or experience only mild symptoms.

Newswise: 0815UCI20052-1069-768x512.jpg
Released: 28-Oct-2020 1:05 PM EDT
Antibody screening finds COVID-19 nearly 7 times more prevalent in O.C. than thought
University of California, Irvine

Irvine, Calif., Oct. 28, 2020 — Testing a representative sample of Orange County residents for a wide range of coronavirus antibodies, University of California, Irvine researchers found that 11.5 percent of them have antibodies for COVID-19, in contrast to previous estimates of less than 2 percent. Latino and low-income residents had the highest prevalence of SARS-CoV-02 antibodies with rates of 17 percent and 15 percent, respectively.

Released: 28-Oct-2020 1:05 PM EDT
Researchers find confusion over masks for wildfire, COVID-19 crises
Stanford School of Earth, Energy & Environmental Sciences

To mask or not to mask - and which mask to use? With public health guidance about masks in the United States confused by political hedging, clarity around mask use is increasingly important, especially as the western U.S. battles the twin crises of wildfire smoke and COVID-19.

Showing results

110 of 3821